Relaxin enhances proliferation, adhesion and invasion in vitro as well as tumour growth in the TRAMP mouse model in vivo, while deficiency of RXFP1 antagonizes this effect [5, 7]. The gene discussed is RXFP1; the disease is neoplasm.